Cargando…

Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis

BACKGROUND: The aim of the present study was to analyse the incidence, risk ratio (RR) and prognoses of two types of medication-related osteonecrosis of the jaws (MRONJ): denosumab-related osteonecrosis of the jaws (DRONJ) and Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ) in cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limones, Alvaro, Sáez-Alcaide, Luis Miguel, Díaz-Parreño, Santiago Angulo, Helm, Alexandra, Bornstein, Michael M., Molinero-Mourelle, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medicina Oral S.L. 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211372/ https://www.ncbi.nlm.nih.gov/pubmed/32271321 http://dx.doi.org/10.4317/medoral.23324

Ejemplares similares

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Denosumab/ibandronic acid/zoledronic acid: Medication-related osteonecrosis of jaw: case report
Publicado: (2021)

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021)

Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Migliorati, Cesar Augusto
Publicado: (2022)

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022)

Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ
por: Roato, Ilaria, et al.
Publicado: (2023)

Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ)
por: Jowett, Adam, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report
por: Samieirad, Sahand, et al.
Publicado: (2021)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Nica, Diana Florina, et al.
Publicado: (2021)

Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study
por: Varoni, Elena M., et al.
Publicado: (2021)

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021)

Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review
por: Gkouveris, Ioannis, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
por: Rosales, Hemil Dario, et al.
Publicado: (2023)

Denosumab Related Osteonecrosis of Jaw: a Case Report
por: de Sales Lima, Marco Vinícius, et al.
Publicado: (2018)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
por: Shibahara, Takahiko
Publicado: (2019)

Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
por: Okuyama, Kohei, et al.
Publicado: (2021)

Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
por: Gaudet, Camille, et al.
Publicado: (2022)

Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies
por: Muttanahally, Kavya Shankar, et al.
Publicado: (2023)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
por: Fusco, Vittorio, et al.
Publicado: (2018)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
por: Neuprez, A., et al.
Publicado: (2013)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016)

Dental extraction following zoledronate, induces osteonecrosis in rat´s jaw
por: Vidal-Gutiérrez, Ximena, et al.
Publicado: (2017)

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)
por: Fusco, Vittorio, et al.
Publicado: (2022)

Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England
por: Sturrock, Andrew, et al.
Publicado: (2019)

New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures
por: Laimer, Johannes, et al.
Publicado: (2021)

Assessment of clinical outcomes and histomorphometric findings in alveolar ridge augmentation procedures with allogeneic bone block grafts: A systematic review and meta-analysis
por: Pérez-González, Fabián, et al.
Publicado: (2020)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
por: Alsalih, Aya, et al.
Publicado: (2021)

Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology
por: Raje, Noopur, et al.
Publicado: (2019)

The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)
por: Cano-Durán, Jorge A., et al.
Publicado: (2017)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
por: Al Abdullateef, Abdulrhman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2pt9qgvjhllnp2tst23nk7evh